Biogen BIIB Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Biogen in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Biogen’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biogen's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biogen's deferred tax assets and other non-current assets?
- Biogen (BIIB) reported deferred tax assets and other non-current assets of $777.5M in Q1 2026.
- How has Biogen's deferred tax assets and other non-current assets changed year-over-year?
- Biogen's deferred tax assets and other non-current assets increased by 39.1% year-over-year, from $559.1M to $777.5M.
- What is the long-term trend for Biogen's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Biogen's deferred tax assets and other non-current assets has grown at a 48.7% compound annual growth rate (CAGR), from $103.1M to $750.6M.